Sarcopenia and Mortality in Critically Ill COVID-19 Patients
COVID-19 can manifest as either asymptomatic or progressing to a severe phase in some patients, which may require hospitalization. These patients may experience dyspnea and hypoxia, leading to the development of acute respiratory distress syndrome. Studies have reported an increased risk of severe s...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-12-01
|
| Series: | Life |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-1729/14/1/24 |
| _version_ | 1827371648600244224 |
|---|---|
| author | Fatima Al Zahra Yakti Lana Abusalah Vijay Ganji |
| author_facet | Fatima Al Zahra Yakti Lana Abusalah Vijay Ganji |
| author_sort | Fatima Al Zahra Yakti |
| collection | DOAJ |
| description | COVID-19 can manifest as either asymptomatic or progressing to a severe phase in some patients, which may require hospitalization. These patients may experience dyspnea and hypoxia, leading to the development of acute respiratory distress syndrome. Studies have reported an increased risk of severe sarcopenia in COVID-19 patients during and after recovery. This narrative review aimed to summarize and synthesize available studies on the association between sarcopenia and mortality in critically ill COVID-19 patients. A total of 22 studies conducted on hospitalized COVID-19 patients were included in this review. Of those, 17 studies reported a direct association, while 5 studies showed no association between sarcopenia and mortality in severe COVID-19 patients. It is important to maintain muscle quality and quantity in defense against COVID-19. The measurement of lean muscle mass should be included in the risk assessment of severely ill COVID-19 patients as part of the therapy plan. |
| first_indexed | 2024-03-08T10:44:32Z |
| format | Article |
| id | doaj.art-a01d630cc5d641a5a6d72d76c0fbe9af |
| institution | Directory Open Access Journal |
| issn | 2075-1729 |
| language | English |
| last_indexed | 2024-03-08T10:44:32Z |
| publishDate | 2023-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Life |
| spelling | doaj.art-a01d630cc5d641a5a6d72d76c0fbe9af2024-01-26T17:20:26ZengMDPI AGLife2075-17292023-12-011412410.3390/life14010024Sarcopenia and Mortality in Critically Ill COVID-19 PatientsFatima Al Zahra Yakti0Lana Abusalah1Vijay Ganji2Human Nutrition Department, College of Health Sciences, QU Health, Qatar University, Doha P.O. Box 2713, QatarHuman Nutrition Department, College of Health Sciences, QU Health, Qatar University, Doha P.O. Box 2713, QatarDepartment of Nutrition and Dietetics, School of Health and Human Sciences, Indiana University Indianapolis, 1050 Wishard Blvd., Indianapolis, IN 46202, USACOVID-19 can manifest as either asymptomatic or progressing to a severe phase in some patients, which may require hospitalization. These patients may experience dyspnea and hypoxia, leading to the development of acute respiratory distress syndrome. Studies have reported an increased risk of severe sarcopenia in COVID-19 patients during and after recovery. This narrative review aimed to summarize and synthesize available studies on the association between sarcopenia and mortality in critically ill COVID-19 patients. A total of 22 studies conducted on hospitalized COVID-19 patients were included in this review. Of those, 17 studies reported a direct association, while 5 studies showed no association between sarcopenia and mortality in severe COVID-19 patients. It is important to maintain muscle quality and quantity in defense against COVID-19. The measurement of lean muscle mass should be included in the risk assessment of severely ill COVID-19 patients as part of the therapy plan.https://www.mdpi.com/2075-1729/14/1/24sarcopeniamuscle massCOVID-19coronavirusSARS-CoV-2mortality |
| spellingShingle | Fatima Al Zahra Yakti Lana Abusalah Vijay Ganji Sarcopenia and Mortality in Critically Ill COVID-19 Patients Life sarcopenia muscle mass COVID-19 coronavirus SARS-CoV-2 mortality |
| title | Sarcopenia and Mortality in Critically Ill COVID-19 Patients |
| title_full | Sarcopenia and Mortality in Critically Ill COVID-19 Patients |
| title_fullStr | Sarcopenia and Mortality in Critically Ill COVID-19 Patients |
| title_full_unstemmed | Sarcopenia and Mortality in Critically Ill COVID-19 Patients |
| title_short | Sarcopenia and Mortality in Critically Ill COVID-19 Patients |
| title_sort | sarcopenia and mortality in critically ill covid 19 patients |
| topic | sarcopenia muscle mass COVID-19 coronavirus SARS-CoV-2 mortality |
| url | https://www.mdpi.com/2075-1729/14/1/24 |
| work_keys_str_mv | AT fatimaalzahrayakti sarcopeniaandmortalityincriticallyillcovid19patients AT lanaabusalah sarcopeniaandmortalityincriticallyillcovid19patients AT vijayganji sarcopeniaandmortalityincriticallyillcovid19patients |